Overview

The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study is to collect the information of Ultravist® in the patients indicated for the coronary angiography or PCI, like rate of ADR in patients, the dose for different indications, image quality to prove Ultravist the good safety and effectivity
Details
Lead Sponsor:
Bayer